IGC Pharma (IGC) Enterprise Value (2010 - 2026)
IGC Pharma (IGC) reported Enterprise Value of -$263000.0 for Q1 2026, up 35.06% year-over-year from -$194725.8 in Q1 2025, and up 73.05% quarter-over-quarter from -$976000.0 in Q4 2025.
IGC Pharma (IGC) Enterprise Value (2010 - 2026) Analysis & Trends
IGC Pharma (IGC) has 17 years of Enterprise Value data on file, last reported at -$263000.0 in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$263000.0, up 35.06% year-over-year; the trailing twelve-month figure through Mar 2026 was -$263000.0 (up 35.06% YoY), and the FY2026 annual result was -$263000.0, up 35.06% from the prior year.
- Enterprise Value improved to -$263000.0 in Q1 2026 per IGC's latest filing, from -$976000.0 in the prior quarter.
- Over five years, Enterprise Value peaked at -$263000.0 in Q1 2026 and troughed at -$10.5 million in Q1 2022.
- A 5-year average of -$2.9 million and a median of -$1.5 million in 2024 frame the typical range for Enterprise Value.
- On a YoY basis, Enterprise Value climbed as much as 75.11% in 2025 and fell as far as 107.66% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$5.1 million in 2022, then surged by 73.09% to -$1.4 million in 2023, then soared by 65.89% to -$470000.0 in 2024, then tumbled by 107.66% to -$976000.0 in 2025, then surged by 73.05% to -$263000.0 in 2026.
- Business Quant data shows IGC's Enterprise Value at -$263000.0 in Q1 2026, -$976000.0 in Q4 2025, and -$1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -584.73 Mn |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | -263,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -263,000.00 |
| Dec 31, 2025 | -976,000.00 |
| Sep 30, 2025 | -1.16 Mn |
| Jun 30, 2025 | -454,000.00 |
| Mar 31, 2025 | -405,000.00 |
| Dec 31, 2024 | -470,000.00 |
| Sep 30, 2024 | -1.55 Mn |
| Jun 30, 2024 | -1.82 Mn |
| Mar 31, 2024 | -1.20 Mn |
| Dec 31, 2023 | -1.38 Mn |
| Sep 30, 2023 | -3.12 Mn |
| Jun 30, 2023 | -2.18 Mn |
| Mar 31, 2023 | -3.50 Mn |
| Dec 31, 2022 | -5.12 Mn |
| Sep 30, 2022 | -6.82 Mn |
| Jun 30, 2022 | -8.05 Mn |
| Mar 31, 2022 | -10.46 Mn |
| Dec 31, 2021 | -11.94 Mn |
| Sep 30, 2021 | -14.40 Mn |
| Jun 30, 2021 | -13.32 Mn |